Clin2
NCT06385184Likely a fitRecruiting

Social life and quality of life in Parkinson's

Parkinson Disease

Part of Brain & nervous system clinical trials.

This study looks at how social life and quality of life are affected in Parkinson's disease. It compares people with Parkinson's to those without to better understand these changes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
40 years and older
Study type
Observational

Who can take part

  • You must be 40 years old or older.
  • If you have Parkinson's, a doctor must have diagnosed you.
  • You cannot have autism or another developmental disability like Down syndrome.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07488351Recruiting
Self-kindness and confidence in Parkinson's: symptoms, function, quality of life

This study looks at how self-compassion and self-belief affect symptoms, daily function, and quality of life in people with Parkinson's disease. It aims to help researchers understand how emotional well-being relates to physical health.

Istanbul, Turkey
NCT06487364Recruiting
How much change in a Parkinson's quality-of-life test matters

This study looks at a short questionnaire (Parkinson's Disease Questionnaire-8) that measures how Parkinson's affects your daily life. The goal is to find out the smallest change in the questionnaire that really matters to patients.

Istanbul
NCT06908460Recruiting
Parkinson's nursing home staff training and quality of life study

This trial tests whether training nursing home staff can improve the quality of life for residents with Parkinson's disease. The training may help staff better support residents' specific needs.

Grenoble
NCT05779475Enrolling by invitation
Study of people with moderate Parkinson’s disease

This is an observational study, meaning it doesn’t test a new drug—researchers mainly follow people to better understand moderate Parkinson’s disease and who may be good candidates for future cell therapy. If you have moderate symptoms that aren’t well controlled with tablets, this study may help inform better future treatments.

Irvine, California
NCT06965374Recruiting
Study of a new Parkinson's injection and quality of life

This study is looking at how a new continuous 24-hour injection treatment (foslevodopa/foscarbidopa) affects quality of life in people with advanced Parkinson's disease. It is a real-world study, meaning you just take the medication as your doctor prescribes, and researchers observe the results.

Troina, Enna
NCT05266872Recruiting
Earlier diagnosis and better treatment study for Parkinson’s

This study is looking to improve how Parkinson’s and related brain conditions are identified and treated sooner. You may be asked to share your health information and provide blood or other samples, and possibly have procedures like a spinal fluid test or a small skin sample.

Luxembourg

Hear when a new Parkinson Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.